FDA Blocks Imports From Another Ranbaxy Drug Plant
The U.S. Food and Drug Administration on Friday forbade the importation of drugs from a Ranbaxy Laboratories Inc. plant in India after investigators uncovered rampant violations of U.S.-promulgated manufacturing standards, another...To view the full article, register now.
Already a subscriber? Click here to view full article